United States Expressed Competent Cells Market Report 2017

December 2017 | 109 pages | ID: UE2EBA8B949EN
QYResearch

Abstracts

In this report, the United States Expressed Competent Cells market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Expressed Competent Cells in these regions, from 2012 to 2022 (forecast).

United States Expressed Competent Cells market competition by top manufacturers/players, with Expressed Competent Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck KGaA
• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio
• Promega Corporation
• Beijing TransGen Biotech
• GeneScript Corporation
• Yeastern Biotech
• New England Biolabs
• QIAGEN N.V.
• OriGene Technologies
• Lucigen
• Zymo Research
• Bio-Rad Laboratories
• Bioline
• Delphi Genetics
• IBA GmBH
• Cell Applications
• BioDynamics Laboratory
• Scarab Genomics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Chemically Competent Cells
• Electrocompetent Cells

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Protein Expression
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Expressed Competent Cells Market Report 2017

1 EXPRESSED COMPETENT CELLS OVERVIEW

1.1 Product Overview and Scope of Expressed Competent Cells
1.2 Classification of Expressed Competent Cells by Product Category
  1.2.1 United States Expressed Competent Cells Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Expressed Competent Cells Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Chemically Competent Cells
  1.2.4 Electrocompetent Cells
1.3 United States Expressed Competent Cells Market by Application/End Users
  1.3.1 United States Expressed Competent Cells Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Protein Expression
  1.3.3 Other
1.4 United States Expressed Competent Cells Market by Region
  1.4.1 United States Expressed Competent Cells Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Expressed Competent Cells Status and Prospect (2012-2022)
  1.4.3 Southwest Expressed Competent Cells Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Expressed Competent Cells Status and Prospect (2012-2022)
  1.4.5 New England Expressed Competent Cells Status and Prospect (2012-2022)
  1.4.6 The South Expressed Competent Cells Status and Prospect (2012-2022)
  1.4.7 The Midwest Expressed Competent Cells Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Expressed Competent Cells (2012-2022)
  1.5.1 United States Expressed Competent Cells Sales and Growth Rate (2012-2022)
  1.5.2 United States Expressed Competent Cells Revenue and Growth Rate (2012-2022)

2 UNITED STATES EXPRESSED COMPETENT CELLS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Expressed Competent Cells Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Expressed Competent Cells Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Expressed Competent Cells Average Price by Players/Suppliers (2012-2017)
2.4 United States Expressed Competent Cells Market Competitive Situation and Trends
  2.4.1 United States Expressed Competent Cells Market Concentration Rate
  2.4.2 United States Expressed Competent Cells Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Expressed Competent Cells Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES EXPRESSED COMPETENT CELLS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Expressed Competent Cells Sales and Market Share by Region (2012-2017)
3.2 United States Expressed Competent Cells Revenue and Market Share by Region (2012-2017)
3.3 United States Expressed Competent Cells Price by Region (2012-2017)

4 UNITED STATES EXPRESSED COMPETENT CELLS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Expressed Competent Cells Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Expressed Competent Cells Revenue and Market Share by Type (2012-2017)
4.3 United States Expressed Competent Cells Price by Type (2012-2017)
4.4 United States Expressed Competent Cells Sales Growth Rate by Type (2012-2017)

5 UNITED STATES EXPRESSED COMPETENT CELLS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Expressed Competent Cells Sales and Market Share by Application (2012-2017)
5.2 United States Expressed Competent Cells Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES EXPRESSED COMPETENT CELLS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck KGaA
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Expressed Competent Cells Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck KGaA Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Thermo Fisher Scientific
  6.2.2 Expressed Competent Cells Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Thermo Fisher Scientific Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Agilent Technologies
  6.3.2 Expressed Competent Cells Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Agilent Technologies Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Takara Bio
  6.4.2 Expressed Competent Cells Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Takara Bio Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Promega Corporation
  6.5.2 Expressed Competent Cells Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Promega Corporation Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Beijing TransGen Biotech
  6.6.2 Expressed Competent Cells Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Beijing TransGen Biotech Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GeneScript Corporation
  6.7.2 Expressed Competent Cells Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GeneScript Corporation Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Yeastern Biotech
  6.8.2 Expressed Competent Cells Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Yeastern Biotech Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 New England Biolabs
  6.9.2 Expressed Competent Cells Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 New England Biolabs Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 QIAGEN N.V.
  6.10.2 Expressed Competent Cells Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 QIAGEN N.V. Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 OriGene Technologies
6.12 Lucigen
6.13 Zymo Research
6.14 Bio-Rad Laboratories
6.15 Bioline
6.16 Delphi Genetics
6.17 IBA GmBH
6.18 Cell Applications
6.19 BioDynamics Laboratory
6.20 Scarab Genomics

7 EXPRESSED COMPETENT CELLS MANUFACTURING COST ANALYSIS

7.1 Expressed Competent Cells Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Expressed Competent Cells

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Expressed Competent Cells Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Expressed Competent Cells Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES EXPRESSED COMPETENT CELLS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Expressed Competent Cells Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Expressed Competent Cells Sales Volume Forecast by Type (2017-2022)
11.3 United States Expressed Competent Cells Sales Volume Forecast by Application (2017-2022)
11.4 United States Expressed Competent Cells Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Expressed Competent Cells
Figure United States Expressed Competent Cells Market Size (K Units) by Type (2012-2022)
Figure United States Expressed Competent Cells Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemically Competent Cells Product Picture
Figure Electrocompetent Cells Product Picture
Figure United States Expressed Competent Cells Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Expressed Competent Cells by Application in 2016
Figure Protein Expression Examples
Table Key Downstream Customer in Protein Expression
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Expressed Competent Cells Market Size (Million USD) by Region (2012-2022)
Figure The West Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2022)
Figure United States Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Expressed Competent Cells Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Expressed Competent Cells Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Expressed Competent Cells Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Expressed Competent Cells Sales Share by Players/Suppliers
Figure 2017 United States Expressed Competent Cells Sales Share by Players/Suppliers
Figure United States Expressed Competent Cells Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Expressed Competent Cells Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Expressed Competent Cells Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Expressed Competent Cells Revenue Share by Players/Suppliers
Figure 2017 United States Expressed Competent Cells Revenue Share by Players/Suppliers
Table United States Market Expressed Competent Cells Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Expressed Competent Cells Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Expressed Competent Cells Market Share of Top 3 Players/Suppliers
Figure United States Expressed Competent Cells Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Expressed Competent Cells Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Expressed Competent Cells Product Category
Table United States Expressed Competent Cells Sales (K Units) by Region (2012-2017)
Table United States Expressed Competent Cells Sales Share by Region (2012-2017)
Figure United States Expressed Competent Cells Sales Share by Region (2012-2017)
Figure United States Expressed Competent Cells Sales Market Share by Region in 2016
Table United States Expressed Competent Cells Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Expressed Competent Cells Revenue Share by Region (2012-2017)
Figure United States Expressed Competent Cells Revenue Market Share by Region (2012-2017)
Figure United States Expressed Competent Cells Revenue Market Share by Region in 2016
Table United States Expressed Competent Cells Price (USD/Unit) by Region (2012-2017)
Table United States Expressed Competent Cells Sales (K Units) by Type (2012-2017)
Table United States Expressed Competent Cells Sales Share by Type (2012-2017)
Figure United States Expressed Competent Cells Sales Share by Type (2012-2017)
Figure United States Expressed Competent Cells Sales Market Share by Type in 2016
Table United States Expressed Competent Cells Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Expressed Competent Cells Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Expressed Competent Cells by Type (2012-2017)
Figure Revenue Market Share of Expressed Competent Cells by Type in 2016
Table United States Expressed Competent Cells Price (USD/Unit) by Types (2012-2017)
Figure United States Expressed Competent Cells Sales Growth Rate by Type (2012-2017)
Table United States Expressed Competent Cells Sales (K Units) by Application (2012-2017)
Table United States Expressed Competent Cells Sales Market Share by Application (2012-2017)
Figure United States Expressed Competent Cells Sales Market Share by Application (2012-2017)
Figure United States Expressed Competent Cells Sales Market Share by Application in 2016
Table United States Expressed Competent Cells Sales Growth Rate by Application (2012-2017)
Figure United States Expressed Competent Cells Sales Growth Rate by Application (2012-2017)
Table Merck KGaA Basic Information List
Table Merck KGaA Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure Merck KGaA Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure Merck KGaA Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Agilent Technologies Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure Agilent Technologies Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure Agilent Technologies Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table Takara Bio Basic Information List
Table Takara Bio Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takara Bio Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure Takara Bio Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure Takara Bio Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table Promega Corporation Basic Information List
Table Promega Corporation Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Promega Corporation Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure Promega Corporation Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure Promega Corporation Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table Beijing TransGen Biotech Basic Information List
Table Beijing TransGen Biotech Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beijing TransGen Biotech Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure Beijing TransGen Biotech Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure Beijing TransGen Biotech Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table GeneScript Corporation Basic Information List
Table GeneScript Corporation Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GeneScript Corporation Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure GeneScript Corporation Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure GeneScript Corporation Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table Yeastern Biotech Basic Information List
Table Yeastern Biotech Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Yeastern Biotech Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure Yeastern Biotech Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure Yeastern Biotech Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table New England Biolabs Basic Information List
Table New England Biolabs Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure New England Biolabs Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure New England Biolabs Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure New England Biolabs Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table QIAGEN N.V. Basic Information List
Table QIAGEN N.V. Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QIAGEN N.V. Expressed Competent Cells Sales Growth Rate (2012-2017)
Figure QIAGEN N.V. Expressed Competent Cells Sales Market Share in United States (2012-2017)
Figure QIAGEN N.V. Expressed Competent Cells Revenue Market Share in United States (2012-2017)
Table OriGene Technologies Basic Information List
Table Lucigen Basic Information List
Table Zymo Research Basic Information List
Table Bio-Rad Laboratories Basic Information List
Table Bioline Basic Information List
Table Delphi Genetics Basic Information List
Table IBA GmBH Basic Information List
Table Cell Applications Basic Information List
Table BioDynamics Laboratory Basic Information List
Table Scarab Genomics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Expressed Competent Cells
Figure Manufacturing Process Analysis of Expressed Competent Cells
Figure Expressed Competent Cells Industrial Chain Analysis
Table Raw Materials Sources of Expressed Competent Cells Major Players/Suppliers in 2016
Table Major Buyers of Expressed Competent Cells
Table Distributors/Traders List
Figure United States Expressed Competent Cells Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Expressed Competent Cells Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Expressed Competent Cells Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Expressed Competent Cells Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Expressed Competent Cells Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Expressed Competent Cells Sales Volume (K Units) Forecast by Type in 2022
Table United States Expressed Competent Cells Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Expressed Competent Cells Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Expressed Competent Cells Sales Volume (K Units) Forecast by Application in 2022
Table United States Expressed Competent Cells Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Expressed Competent Cells Sales Volume Share Forecast by Region (2017-2022)
Figure United States Expressed Competent Cells Sales Volume Share Forecast by Region (2017-2022)
Figure United States Expressed Competent Cells Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources